MS
BMY icon

Mizuho Securities’s Bristol-Myers Squibb BMY Stock Holding History

Mizuho Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$4.15K – 82
2024
Q2 		$4.15K Buy
+100
New +$4.47K 0.01% 81
2022
Q4 		– Sell
-101
Closed -$7K – 98
2022
Q3 		$7K Buy
101
+2
+2% +$145 ﹤0.01% 97
2022
Q2 		$6K Sell
99
-240
-71% -$18.3K ﹤0.01% 130
2022
Q1 		$25K Buy
339
+239
+239% +$16K 0.01% 90
2021
Q4 		$6K Buy
100
+1
+1% +$59 ﹤0.01% 121
2021
Q3 		$6K Hold
99
– – ﹤0.01% 129
2021
Q2 		$7K Buy
99
+2
+2% +$130 ﹤0.01% 116
2021
Q1 		$6K Sell
97
-40
-29% -$2.49K ﹤0.01% 104
2020
Q4 		$8K Buy
+137
New +$8.42K ﹤0.01% 99

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mizuho Securities's BMY Position: Q3 2024 in Review

Mizuho Securities sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 100 shares — an estimated $4.15K sold.

Mizuho Securities first reported a position in BMY in Q4 2020 and held it in 9 quarters. The position peaked at $25K in Q1 2022. 2,265 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Mizuho Securities reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Mizuho Securities sold 100 Bristol-Myers Squibb shares in Q3 2024, an estimated $4.15K.
  • Mizuho Securities first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 9 quarters.
  • Mizuho Securities's Bristol-Myers Squibb position peaked at $25K in Q1 2022.
  • 2,265 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Mizuho Securities's 13F filing for Q3 2024, filed 6 Nov 2024.